annual EBITDA:
$153.92M+$45.10M(+41.44%)Summary
- As of today (June 2, 2025), GDRX annual EBITDA is $153.92 million, with the most recent change of +$45.10 million (+41.44%) on December 31, 2024.
- During the last 3 years, GDRX annual EBITDA has risen by +$105.92 million (+220.64%).
- GDRX annual EBITDA is now at all-time high.
Performance
GDRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$48.22M+$6.36M(+15.19%)Summary
- As of today (June 2, 2025), GDRX quarterly EBITDA is $48.22 million, with the most recent change of +$6.36 million (+15.19%) on March 31, 2025.
- Over the past year, GDRX quarterly EBITDA has increased by +$17.35 million (+56.18%).
- GDRX quarterly EBITDA is now at all-time high.
Performance
GDRX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$171.27M+$17.35M(+11.27%)Summary
- As of today (June 2, 2025), GDRX TTM EBITDA is $171.27 million, with the most recent change of +$17.35 million (+11.27%) on March 31, 2025.
- Over the past year, GDRX TTM EBITDA has increased by +$63.23 million (+58.53%).
- GDRX TTM EBITDA is now at all-time high.
Performance
GDRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GDRX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +41.4% | +56.2% | +58.5% |
| 3 y3 years | +220.6% | +54.6% | +117.3% |
| 5 y5 years | +5.3% | +0.3% | +40.3% |
GDRX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +220.6% | at high | +4119.1% | at high | +163.9% |
| 5 y | 5-year | at high | +159.9% | at high | +116.3% | at high | +149.9% |
| alltime | all time | at high | +159.9% | at high | +116.3% | at high | +149.9% |
GDRX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $48.22M(+15.2%) | $171.27M(+11.3%) |
| Dec 2024 | $153.92M(+41.4%) | $41.86M(+10.2%) | $153.92M(+5.5%) |
| Sep 2024 | - | $38.00M(-12.0%) | $145.85M(+33.8%) |
| Jun 2024 | - | $43.18M(+39.8%) | $108.99M(+0.9%) |
| Mar 2024 | - | $30.88M(-8.6%) | $108.03M(-0.7%) |
| Dec 2023 | $108.82M(+66.9%) | $33.79M(+2856.6%) | $108.82M(+11.3%) |
| Sep 2023 | - | $1.14M(-97.3%) | $97.75M(-0.0%) |
| Jun 2023 | - | $42.22M(+33.3%) | $97.76M(+48.9%) |
| Mar 2023 | - | $31.67M(+39.4%) | $65.67M(+0.7%) |
| Dec 2022 | $65.19M | $22.71M(+1859.9%) | $65.19M(+0.5%) |
| Sep 2022 | - | $1.16M(-88.6%) | $64.89M(-19.8%) |
| Jun 2022 | - | $10.13M(-67.5%) | $80.91M(+2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $31.19M(+39.1%) | $78.81M(+64.2%) |
| Dec 2021 | $48.00M(-118.7%) | $22.42M(+30.6%) | $48.00M(-117.8%) |
| Sep 2021 | - | $17.17M(+113.8%) | -$269.43M(-21.5%) |
| Jun 2021 | - | $8.03M(+2019.0%) | -$343.11M(+12.6%) |
| Mar 2021 | - | $379.00K(-100.1%) | -$304.82M(+18.6%) |
| Dec 2020 | -$257.11M(-276.0%) | -$295.01M(+422.1%) | -$257.11M(-466.4%) |
| Sep 2020 | - | -$56.50M(-222.0%) | $70.18M(-58.3%) |
| Jun 2020 | - | $46.31M(-3.7%) | $168.41M(+37.9%) |
| Mar 2020 | - | $48.09M(+49.0%) | $122.10M(+65.0%) |
| Dec 2019 | $146.12M(+73.2%) | $32.27M(-22.7%) | $74.00M(+77.3%) |
| Sep 2019 | - | $41.73M | $41.73M |
| Dec 2018 | $84.35M | - | - |
FAQ
- What is GoodRx Holdings annual EBITDA?
- What is the all time high annual EBITDA for GoodRx Holdings?
- What is GoodRx Holdings annual EBITDA year-on-year change?
- What is GoodRx Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for GoodRx Holdings?
- What is GoodRx Holdings quarterly EBITDA year-on-year change?
- What is GoodRx Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for GoodRx Holdings?
- What is GoodRx Holdings TTM EBITDA year-on-year change?
What is GoodRx Holdings annual EBITDA?
The current annual EBITDA of GDRX is $153.92M
What is the all time high annual EBITDA for GoodRx Holdings?
GoodRx Holdings all-time high annual EBITDA is $153.92M
What is GoodRx Holdings annual EBITDA year-on-year change?
Over the past year, GDRX annual EBITDA has changed by +$45.10M (+41.44%)
What is GoodRx Holdings quarterly EBITDA?
The current quarterly EBITDA of GDRX is $48.22M
What is the all time high quarterly EBITDA for GoodRx Holdings?
GoodRx Holdings all-time high quarterly EBITDA is $48.22M
What is GoodRx Holdings quarterly EBITDA year-on-year change?
Over the past year, GDRX quarterly EBITDA has changed by +$17.35M (+56.18%)
What is GoodRx Holdings TTM EBITDA?
The current TTM EBITDA of GDRX is $171.27M
What is the all time high TTM EBITDA for GoodRx Holdings?
GoodRx Holdings all-time high TTM EBITDA is $171.27M
What is GoodRx Holdings TTM EBITDA year-on-year change?
Over the past year, GDRX TTM EBITDA has changed by +$63.23M (+58.53%)